The phase I INSIGHT platform trial: Safety data from stratum D of evaluating feasibility and safety of eftilagimod alpha (soluble LAG-3 protein) combined with avelumab in advanced stage solid tumor entities
ONCOLOGY RESEARCH AND TREATMENT(2020)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要